MiR-34a |
Silent information regulator 1 (Sirt1) |
MiR-34a has been found to target silent information regulator 1 (Sirt1), leading to cell cycle arrest or apoptosis |
Antiangiogenesis |
[67] |
MiR-107 |
HIF-1β
|
MiR-107 decreases hypoxia signaling by suppressing expression HIF-1β
|
Antiangiogenesis |
[75] |
MiR-132 |
p120RasGAP |
MiR-132 acts as an angiogenic switch by targeting p120RasGAP in the endothelium and thereby inducing neovascularization |
Angiogenesis |
[76] |
MiR-424 |
Cullin 2 (CUL2) |
MiR-424 targeted Cullin 2 (CUL2), a scaffolding protein critical to the assembly of the ubiquitin ligase system, thereby stabilizing HIF-α isoforms |
Angiogenesis |
[77] |
MiR-93 |
Integrin-β8 |
MiR-93 promotes angiogenesis by suppressing integrin-β8 expression |
Angiogenesis |
[71] |
MiR-29b |
MMP-2 |
MiR-29b exerted its antiangiogenesis function, at least partly, by suppressing MMP-2 expression in tumor cells |
Antiangiogenesis |
[78] |
MiR-519c |
HIF-1α
|
Overexpression of miR-519c resulted in a significant decrease of HIF-1α protein levels and reduced the tube formation of human umbilical vein endothelial cells |
Antiangiogenesis |
[79] |
MiR-210 |
VEGF and VEGFR |
Overexpression of miR-210 enhances VEGF and VEGFR2 expression and promotes angiogenesis |
Angiogenesis |
[80] |
MiR-155 |
Von Hippel-Lindau (VHL) |
MiR-155 has a pivotal role in tumor angiogenesis by downregulation of VHL |
Angiogenesis |
[81] |
MiR-195 |
VEGF, VAV2, CDC42 |
MiR-195 directly inhibited the expression of the proangiogenic factor VEGF and the prometastatic factors VAV2 and CDC42 |
Antiangiogenesis |
[82] |
MiR-145 |
HIF-2α
|
MiR-145 suppresses HIF-2α expression, thus inhibiting the angiogenesis |
Antiangiogenesis |
[83] |
MiR-26a |
HGF-hepatocyte growth factor receptor (cMet) |
MiR-26a exerted its antiangiogenesis function, at least in part, by inhibiting HGF-hepatocyte growth factor (cMet) and its downstream signaling pathway |
Antiangiogenesis |
[84] |
MiR-214 |
Hepatoma-derived growth factor (HDGF) |
Downregulation of miR-214 contributes to the unusual hypervascularity of HCC via activation of the HDGF paracrine pathway for tumor angiogenesis |
Antiangiogenesis |
[85] |
MiRNA-24 |
eNOS |
Inhibition of microRNA-24 improves reparative angiogenesis in myocardial infarction |
Antiangiogenesis |
[86] |
MiR-29a |
Phosphatase and tensin homolog (PTEN) |
TGF-β-regulated miRNA in promoting angiogenesis by targeting PTEN to stimulate AKT activity |
Angiogenesis |
[87] |
MiR-27b |
Vascular endothelial growth factor C (VEGFC) |
MiRNA-27b targets vascular endothelial growth factor C to inhibit angiogenesis in colorectal cancer |
Antiangiogenesis |
[88] |
MiR-503 |
FGF2 and VEGF-A |
Demonstrate the antiangiogenesis role of miR-503 in tumorigenesis and provide a novel mechanism for hypoxia-induced FGF2 and VEGF-A through HIF1α-mediated inhibition of miR-503 |
Antiangiogenesis |
[89] |
MiR-143 |
Insulin-like growth factor-I receptor (IGF-IR) |
Overexpression of miR-143 inhibited cell proliferation, migration, tumor growth, and angiogenesis and increased chemosensitivity to oxaliplatin treatment in an IGF-IR-dependent manner |
Antiangiogenesis |
[90] |
MiR-382 |
Phosphatase and tensin homolog (PTEN) |
MiR-382 induced by hypoxia promotes angiogenesis and acts as an angiogenic oncogene by repressing PTEN |
Angiogenesis |
[91] |
MiR-210 |
Vascular endothelial growth factor (VEGF) |
MiR-210 is a key factor at the microRNA level in promoting angiogenesis and neurogenesis, which was associated with local increased vascular endothelial growth factor (VEGF) levels |
Angiogenesis |
[92] |
MiR-542-3p |
Angiopoietin-2 (Angpt2) |
MiR-542-3p inhibited translation of Angpt2 mRNA by binding to its 3′ UTR, and the addition of miR-542-3p to cultured endothelial cells attenuated angiogenesis |
Antiangiogenesis |
[93] |
MiR-214 |
Quaking |
MiR-214 directly targets Quaking, a protein critical for vascular development. Quaking knockdown reduced proangiogenic growth factor expression and inhibited endothelial cell sprouting similar to miR-214 overexpression |
Antiangiogenesis |
[94] |
MiR-20a |
p300 |
P300 drives an angiogenic transcription program during hypertrophy that is fine-tuned in part through direct repression of p300 by miR-20a |
Antiangiogenesis |
[95] |
MiR-15a |
FGF2 and VEGF |
MiR-15a negatively regulates angiogenesis in vivo and in vitro by suppression of FGF2 and VEGF |
Antiangiogenesis |
[96] |